(Q40560543)

English

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity (English)

1 reference

Europe PubMed Central

21 September 2017

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

21 September 2017

7

object named as

Huanchun Chen

1 reference

Europe PubMed Central

21 September 2017

author name string

Gaoyuan Xu

1

1 reference

Europe PubMed Central

21 September 2017

Xiaojuan Xu

2

1 reference

Europe PubMed Central

21 September 2017

Zili Li

3

1 reference

Europe PubMed Central

21 September 2017

Qigai He

4

1 reference

Europe PubMed Central

21 September 2017

Shengfu Sun

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

15-16

1 reference

Europe PubMed Central

21 September 2017

1846-1853

1 reference

Europe PubMed Central

21 September 2017

Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

The development and application of the latex agglutination test to detect serum antibodies against Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Site-specific insertion of DNA into a pseudorabies virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Pseudorabies virus as a live virus vector for expression of foreign genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.09.015

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40560543&oldid=1900567335"